This academic-industry partnership reflects the need for a multidisciplinary approach to innovation in cell and gene therapy manufacturing.

Study shows social isolation following immune challenge is self-imposed and driven by an active neural process, rather than a secondary consequence of physiological symptoms of sickness.

Actuate Therapeutics sees opportunity in the daunting numbers associated with metastatic pancreatic cancer: That stage of the disease accounts for approximately 80-85% of all pancreatic cancer ...

The U.S. Pharmacopeia has created new standards to support the emerging field of advanced cell and gene therapies.

Precipitation-based purification method could replace current Protein A–reliant methods, significantly reducing manufacturing costs of mAbs.

Sustainable bioprocessing boosts cyanobacterial pigment production for advanced biomedical, imaging, and commercial applications.

Multiple microbial communities populate cleanrooms, regardless of grade, and aren’t detected by standard monitoring methods.

The U.S. is AstraZeneca’s largest market by sales and is also home to 19 R&D, manufacturing, and commercial sites.

EVE is a deep generative model combining evolutionary and human population data to estimate variant deleteriousness on a proteome-wide scale.